Gene: C1orf50
Official Full Name: chromosome 1 open reading frame 50provided by HGNC
Gene Summary: Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19335 | C1orf50 Knockout cell line (HeLa) | Human | C1orf50 | 1:3~1:6 | Negative | Online Inquiry |
KO19336 | C1orf50 Knockout cell line (HCT 116) | Human | C1orf50 | 1:2~1:4 | Negative | Online Inquiry |
KO19337 | C1orf50 Knockout cell line (HEK293) | Human | C1orf50 | 1:3~1:6 | Negative | Online Inquiry |
KO19338 | C1orf50 Knockout cell line (A549) | Human | C1orf50 | 1:3~1:4 | Negative | Online Inquiry |
C1orf50 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to study the functional roles of the C1orf50 gene, which has garnered attention due to its potential implications in various biological processes and pathologies. These knockout cell lines provide researchers with a unique tool for elucidating the gene's function by creating a loss-of-function scenario, thus allowing for the analysis of phenotypic consequences resulting from the absence of C1orf50 expression.
The key function of these knockout cell lines lies in their ability to facilitate in-depth investigations into the underlying mechanisms by which C1orf50 influences cellular processes such as proliferation, differentiation, and responses to external stressors. Utilizing CRISPR-Cas9 gene editing technology, these lines achieve precise excision of the C1orf50 locus, ensuring a complete loss of gene activity. This meticulous methodology ensures that researchers can confidently ascribe any observed variations in cellular behavior directly to the absence of C1orf50, enhancing the validity of experimental outcomes.
Scientifically, C1orf50 has been implicated in diverse research areas, including cancer biology, neurobiology, and genetic disorders. The knockout cell lines are invaluable in these contexts, as they enable comprehensive studies of gene function, interactions with other pathways, and potential therapeutic targets. In clinical settings, the insights gathered from these models can be instrumental in the development of gene therapies or novel pharmacological interventions for diseases where C1orf50 plays a critical role.
What distinguishes these C1orf50 Gene Knockout Cell Lines from alternative models is their robust validation and reliability, ensuring researchers obtain consistent and reproducible data. The targeted nature of the C1orf50 knockout mitigates the variability often associated with other gene-modification techniques, significantly enhancing the precision of experimental results.
These cell lines represent a significant advance for researchers and clinicians alike by providing a streamlined approach to understanding gene function in real-time. By utilizing these knockout models, users are more empowered to translate their findings into efficacious clinical applications. Our company has a proven track record of expertise in generating high-quality genetic tools and models designed to accelerate breakthroughs in biological research. With our commitment to precision and reliability, we equip scientists and medical professionals with the resources necessary to advance their work towards innovative solutions in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.